Work

Pharmacological management of attention deficit hyperactivity disorder in children and adolescents

Year: 2025

Type: article

Abstract: Attention deficit hyperactivity disorder (ADHD) is a common neurodevelopmental disorder characterised by developmentally inappropriate levels of hyperactivity, impulsivity and/or inattention, with substantial impact on functioning. Stimulants (methylphenidate, dexamfetamine, lisdexamfetamine) are the main pharmacological treatment for children and adolescents with ADHD and are highly effective at reducing core ADHD symptoms. Non-stimulants such as atomoxetine, clonidine and guanfacine can also be useful in some patients.

Source: Australian Prescriber

DOI: 10.18773/austprescr.2025.043

Authors: Daryl Efron, Nadia Coscini

Institutions: Royal Children's Hospital, The University of Melbourne, Murdoch Children's Research Institute

Language: English

Topic: Attention Deficit Hyperactivity Disorder

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W4414991857

FWCI: 4.918

Cites:

Cited by: 8

Related to: